Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort study

In this retrospective cohort study, we evaluated the efficacy of baricitinib in the treatment of coronavirus disease 2019 (COVID-19). Among 404 adult patients with COVID-19 who were admitted to our hospital between October 23, 2020, and July 31, 2021, 229 patients with respiratory failure were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanimoto, Takuya, Tada, Shinpei, Fujita, Suguru, Hirakawa, Tetsu, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Hamai, Kosuke, Tsuji, Naoki, Hirosawa, Hideyasu, Taniguchi, Tomohiro, Okamoto, Takeshi, Omoto, Takuji, Kusunoki, Shinji, Maeda, Hiroyuki, Ishikawa, Nobuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Respiratory Society. Published by Elsevier B.V. 2022
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898743/
https://www.ncbi.nlm.nih.gov/pubmed/35307364
http://dx.doi.org/10.1016/j.resinv.2022.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898743/
https://www.ncbi.nlm.nih.gov/pubmed/35307364
http://dx.doi.org/10.1016/j.resinv.2022.02.004

Ejemplares similares